 China Vaccine Market Report, 2007-2009
China is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Customs, China's total vaccine import and export volume reached 34,846 tons in the first five months of 2008, of which 7,735 tons were imports, and 27,111 tons were exports.
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
2.000,00$ |
The Global Anti-Addiction Market, 2008-2023
Exclusive visiongain interviews with key opinion leaders in the addiction industry
/ Examination of a wealth of secondary sources, including company reports, filings, analyst presentations and press releases
/ Use of in-house and commercial sales databases
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
3.000,00$ |
The Japanese Pharmaceutical Market 2008-2023
Biennial National Health Insurance drug price reductions
/ Increasing R&D expenses
/ Intensifying competition between domestic companies and foreign international pharmaceutical companies, especially market leaders
/ Restructuring within the pharmaceutical industry in Japan and worldwide
/ Non-a
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
3.000,00$ |
World Gastrointestinal Disorders Market 2008-2023
The current state of the world market for drugs to treat gastrointestinal disorders
/ Drivers and restraints
/ Opportunities and threats
/ Key industrial players in the GI market
/ Revenue trends in the world gastrointestinal market between 2008-2023, including principal submarkets
/ Prospects
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
3.000,00$ |
Oncology Market Leaders - Analyses and Outlook, Market Report 2008-2023
The oncology market will continue to generate high revenues and significant profitability in the years ahead, visiongain concludes. Sales of the leading cancer drugs are increasing worldwide, with greater reliance on those agents as time goes by. Certainly, the future prospects for the major players
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
3.000,00$ |
China Vitamin Market Report, 2007-2008
The period from 2003 to the end of 2006 had witnessed the rapid development of Chinese vitamin manufacturers, they had together played an important role in the international vitamin market via effective means like expansion and integration, during this period, the vitamin price has been steady. The
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
2.500,00$ |
Outsourcing for contract manufacturing services 2008-2023
The revenue for world contract manufacturing business in 2007 was approximately $30bn, with a growth rate of 6% from 2006. The technical expertise and cost savings offered by contract manufacturing organisations (CMOs) make them increasingly essential to you and your organisation. Greater emphasis h
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
2.210,00$ |
Alcon Inc.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Alcon in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive fo
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
5.700,00$ |
F. Hoffmann-La Roche Ltd.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive fo
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
5.700,00$ |
Nycomed A/S: PharmaVitae Profile
This analysis examines the historical and forecast performance for Nycomed in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
5.700,00$ |
Successful Pharmabiotech Alliance Strategies: Driving synergies, avoiding failure and managing relationships
Driving synergies, avoiding failure and managing relationships
""The average value of pharma-biotech deals will almost treble by 2015 as pharma companies focus on gaining exclusive access to high potential technologies via large equity investments...""
In recent years, alliances between pharma and
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
3.835,00$ |
The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
""The global CNS disorders market expanded by 8.0% from 2006, to reach total sales of $77.3bn in 2007. This growth has been primarily driven by treatments for AD, ADHD and Parkinson’s Disease.""
The CNS disorders market is one of the largest and fastest growing markets in the pharmaceutical indust
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
3.835,00$ |
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
""The total RNAi therapy market is estimated to value $580m by 2012. This forecast is based upon current treatments, levels of market satisfaction and five new Phase II/III RNAi agents profiled in this report.""
RNA interference continues to offer significant promise for a host of therapeutic trea
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
3.835,00$ |
Pharmaceuticals - Russia
Pharmaceutical production in Russia
/ Pharmaceutical import in Russia
/ Pharmaceutical drug prices in Russia
/ Pharmaceutical regulatory environment in Russia
/ Pharmaceutical forecasts in Russia
/ Leading pharmaceutical manufacturers, pharmacy chains and distributors in Russia
/ Pharmaceutica
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
590,00€ |
Global Orthopedics
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
250,00$ |
Orthopedics in Asia-Pacific
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
250,00$ |
Orthopedics in Europe
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
250,00$ |
Orthopedics in France
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
250,00$ |
Orthopedics in Germany
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
250,00$ |
Orthopedics in Japan
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
250,00$ |
Orthopedics in the United Kingdom
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
250,00$ |
Orthopedics in the United States
Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
250,00$ |
The Pharmaceutical Wholesale and Distribution Industry Outlook & Analysis 2008
Discussion of the current W&D market
/ Forecast of the big three US wholesalers from 2008-2013
/ Drivers and restraints facing the W&D market
/ Opportunities and threats facing the W&D market
/ Commercial prospects for the W&D market
/ Discussion of unmet needs
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
2.210,00$ |
The World OTC Pharmaceutical Market Analysis & Forecasts, 2008-2023
In particular, this report concentrates on the following essential aspects of the global OTC industry:
/
/ Major therapeutic areas treated by OTC products
/ Key industrial players in the OTC market
/ Financial forecasts covering the period 2008-2023, including leading brands, countries and ther
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
2.210,00$ |
United Kingdom Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2012
The report provides surgical equipment information broken down into detailed categories and segments in United Kingdom.
/ Total revenues, products sold, end users, and average pricing.
/ Market shares of all the key competitors.
/ Key pipeline products that are set to shape the market, broken d
Schwerpunkte: General Pharmaceuticals / Health
|
2008 |
3.000,00$ |
